Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the impact of the EDIT-B4 blood test on patients experiencing a Major Depressive Episode MDE, which can occur in Major Depressive Disorder or bipolar disorder. Bipolar disorder affects about 2% of people worldwide and is often misdiagnosed, leading to delayed treatment and increased suicide risk. This study aims to measure how using EDIT-B4 affects patient management and health outcomes, including economic aspects, over six months. Participants are randomly assigned to one of two groups one where the physician receives the EDIT-B4 test results to guide treatment, and another where the test is performed but results are not shared until the study ends. The EDIT-B4 test involves taking a 2.5 ml blood sample analyzed using RNA sequencing and AI algorithms to differentiate bipolar disorder from major depression. The study involves four visits over six months to monitor changes. During the study, participants depressive symptoms are assessed at inclusion and again at 15-16 weeks to evaluate improvement. Researchers collect data on symptom changes, treatment adjustments, and health economics. The trial will monitor safety and effectiveness of using the test to guide care. Participation requires attending scheduled visits and following the study protocol, with the total involvement lasting about six months.